Toronto Dominion Bank’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.12M Buy
200,800
+10,040
+5% +$106K ﹤0.01% 1124
2025
Q4
$2M Buy
190,760
+15,760
+9% +$164K ﹤0.01% 1119
2025
Q3
$1.81M Sell
175,000
-62,201
-26% -$642K ﹤0.01% 1073
2025
Q2
$2.44M Buy
237,201
+33,496
+16% +$340K ﹤0.01% 918
2025
Q1
$2.05M Buy
+203,705
New +$2.05M ﹤0.01% 932

Other funds holding TDAC

Toronto Dominion Bank's TDAC Position: Q1 2026 in Review

Toronto Dominion Bank increased its Translational Development Acquisition Corp (TDAC) stake by 5.3% in Q1 2026, buying an estimated $106K and bringing the position to 200,800 shares worth $2.12M. The position accounts for ﹤0.01% of the portfolio, ranked #1124.

Toronto Dominion Bank first reported a position in TDAC in Q1 2025 and has held it in 5 quarters since. The position peaked at $2.44M in Q2 2025. 48 funds tracked by Wall St. Rank hold TDAC as of Q1 2026.

  • Toronto Dominion Bank held 200,800 shares of Translational Development Acquisition Corp worth $2.12M as of Q1 2026.
  • Toronto Dominion Bank bought 10,040 Translational Development Acquisition Corp shares in Q1 2026, an estimated $106K.
  • Translational Development Acquisition Corp made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #1124 holding.
  • Toronto Dominion Bank first reported a position in Translational Development Acquisition Corp in Q1 2025 and has held it in 5 quarters since.
  • Toronto Dominion Bank's Translational Development Acquisition Corp position peaked at $2.44M in Q2 2025.
  • 48 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.